Issue 7, 2016

Assessment of polydopamine coated magnetic nanoparticles in doxorubicin delivery

Abstract

Magnetic nanoparticles (MNP) coated with bioinspired polydopamine (PDA) were obtained via a co-precipitation method and oxidative polymerization of dopamine. Nanoparticles were investigated by FTIR, TEM and SQUID. Loading capacity of anticancer drug doxorubicin was determined by UV-Vis spectroscopy. The nanocomposites exhibit a high drug loading capacity of 0.46 mg mg−1. Anticancer activity of the nanocomposites was proved in profound in vitro tests on HeLa cells. Cytotoxicity and internalization of nanoparticles were checked using various method, i.e. proliferation assay (WST-1), a two-colour fluorescence cell viability assay, and fluorescent and confocal microscopy.

Graphical abstract: Assessment of polydopamine coated magnetic nanoparticles in doxorubicin delivery

Supplementary files

Article information

Article type
Paper
Submitted
16 Nov 2015
Accepted
05 Jan 2016
First published
08 Jan 2016

RSC Adv., 2016,6, 5936-5943

Assessment of polydopamine coated magnetic nanoparticles in doxorubicin delivery

R. Mrówczyński, J. Jurga-Stopa, R. Markiewicz, E. L. Coy, S. Jurga and A. Woźniak, RSC Adv., 2016, 6, 5936 DOI: 10.1039/C5RA24222C

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Social activity

Spotlight

Advertisements